Additional Details
- 
                    A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Research SiteTrois-Rivières QC. G8T 7A1View Details
- 
                    A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Research SiteAjax ON. L1S 2J5View Details
- 
                    A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Research SiteEdmonton AB. T6G 2C8View Details
- 
                    A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Research SiteSherbrooke QC. J1H 5N4View Details
- 
                    A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Research SiteVancouver BC. V6Z 2K5View Details
- 
                    Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung DiseaseUniversity of California San FranciscoSan Francisco CA. 94143View Details
- 
                    Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung DiseaseUniversity of MichiganAnn Arbor MI. 48109View Details
- 
                    Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung DiseaseUniversity of KansasKansas City KS. 66103View Details
- 
                    Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung DiseaseUniversity of Colorado DenverAurora CO. 80045View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Oklahoma Heart InstituteTulsa OK. 74104View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)East Carolina University HealthGreenville NC. 27834View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Ohio State Richard M. Ross Heart HospitalColumbus OH. 43210View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)University of Cincinnati Medical CenterCincinnati OH. 45219View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Wakemed Health and HospitalRaleigh NC. 27610-1231View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)University of Maryland Medical CenterBaltimore MD. 21201View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Intermountain Medical CenterMurray UT. 84157View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Temple Lung CenterPhiladelphia PA. 19140View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Houston MethodistHouston TX. 77030View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Tampa General Hospital/University of South Florida HealthTampa FL. 33606View Details
- 
                    DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)New York University Langone Medical CenterNew York NY. 10016View Details
